As with other solid malignancies, BCL-XL and MCL-1 appear to be more important than BCL-2 for cell survival in prostate cancer, although it is likely there is significant inter- and intra-patient heterogeneity [186,211]. The gene discussed is MCL1; the disease is prostate carcinoma.